Receptor state and ligand efficacy

By Chidiac P.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 3, 1995-03 ,pp. : 83-84

Elsevier

Access to resources Recommend Favorite

Family C 7TM Receptor Dimerization and Activation

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 1, 2006-01 ,pp. : 7-16

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen Receptor Modulators: Relationships of Ligand Structure, Receptor Affinity and Functional Activity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 14, 2003-10 ,pp. : 1663-1680

Bentham Science Publishers

Access to resources Recommend Favorite

The ligand paradox between affinity and efficacy: can you be there and not make a difference?

By Kenakin T.   Onaran O.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 6, 2002-06 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite

Anxioselective properties of 6,3'-dinitroflavone, a high-affinity benzodiazepine receptor ligand

By Wolfman C.   Viola H.   Marder M.   Wasowski C.   Ardenghi P.   Izquierdo I.   Paladini A.C.   Medina J.H.  

European Journal of Pharmacology, Vol. 318, Iss. 1, 1996-12 ,pp. : 23-30

Elsevier

Access to resources Recommend Favorite